Technical Analysis for FUM - Futura Medical Plc

Grade Last Price % Change Price Change
C 19.985 21.12% 3.49
FUM closed up 3.13 percent on Wednesday, March 3, 2021, on 63 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical FUM trend table...

Date Alert Name Type % Chg
200 DMA Support Bullish 21.12%
20 DMA Support Bullish 21.12%
Calm After Storm Range Contraction 21.12%
Inside Day Range Contraction 21.12%
Wide Bands Range Expansion 21.12%
Up 3 Days in a Row Strength 21.12%
Crossed Above 200 DMA Bullish 24.91%
Crossed Above 20 DMA Bullish 24.91%
Calm After Storm Range Contraction 24.91%
Wide Bands Range Expansion 24.91%
Older End-of-Day Signals for FUM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Upper Bollinger Band Resistance about 1 hour ago
5x Volume Pace about 3 hours ago
3x Volume Pace about 3 hours ago
2x Volume Pace about 3 hours ago
1.5x Volume Pace about 3 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Futura Medical Plc Description

Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin. It specializes in sexual health and pain relief, and has approximately five products in its development pipeline, which include CSD500, MED2002, TPR100, TIB200 and SPR300. Its CSD500 product incorporates an erectogenic gel (known as Zanifil gel) to help men maintain a firmer erection during intercourse whilst wearing a condom. Its MED2002 is a gel applied directly to the penis for the treatment of male erectile dysfunction (ED). The Company's TPR100 is a gel to provide pain relief. Its SPR300 is a gel, which combines methyl salicylate and menthol with the DermaSys delivery system.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Health Consumer Healthcare Research Pain Pharmaceutical Medicine Pipe Skin Medical Device Drugs Rtt Pharmacology Dosage Forms Absorption Consumer Healthcare Dysfunction Erectile Dysfunction Erection Pharmaceutical Drugs Sexual Health

Is FUM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 24.4865
52 Week Low 7.1601
Average Volume 625,451
200-Day Moving Average 15.66
50-Day Moving Average 15.04
20-Day Moving Average 15.86
10-Day Moving Average 17.29
Average True Range 1.91
ADX 20.25
+DI 24.82
-DI 17.73
Chandelier Exit (Long, 3 ATRs ) 15.27
Chandelier Exit (Short, 3 ATRs ) 18.68
Upper Bollinger Band 19.82
Lower Bollinger Band 11.90
Percent B (%b) 0.58
BandWidth 49.88
MACD Line 0.50
MACD Signal Line 0.58
MACD Histogram -0.0887
Fundamentals Value
Market Cap 40.53 Million
Num Shares 246 Million
EPS -4.80
Price-to-Earnings (P/E) Ratio -3.44
Price-to-Sales 1101.45
Price-to-Book 16.52
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.74
Resistance 3 (R3) 18.66 17.83 18.37
Resistance 2 (R2) 17.83 17.26 17.87 18.24
Resistance 1 (R1) 17.16 16.91 17.50 17.25 18.12
Pivot Point 16.34 16.34 16.50 16.38 16.34
Support 1 (S1) 15.67 15.77 16.00 15.75 14.88
Support 2 (S2) 14.84 15.41 14.89 14.76
Support 3 (S3) 14.18 14.84 14.64
Support 4 (S4) 14.26